BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Adhera, Bayer Subsidiaries Targeting Parkinson’s with Novel Approaches

  Bayer is taking multiple shots at Parkinson’s disease with BlueRock dosing its first patient in a Phase I stem cell study, and AskBio is assessing a gene therapy treatment for the disease.

  June 8, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Will the H10N3 Avian Flu Strain, Now in Humans, Become the Next Pandemic?

  The first human case of H10N3 avian flu was diagnosed in China in late May. Chinese health authorities claim a low risk of contagion. Learn more about it here.

  June 8, 2021

   · 

  3 min read

   · 

  Gail Dutton
• 

  Drug Development

  Byondis’ ADC Candidate Shows Prolonged PFS in HER-2+ Advanced Breast Cancer

  Results from the Phase III TULIP® study show an antibody-drug conjugate from Byondis significantly prolonged PFS in patients with pretreated HER2-positive metastatic breast cancer.

  June 8, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Business

  Biogen’s Aduhelm Win Has Potential to Reinvigorate Alzheimer’s Investment

  Despite controversy over the drug’s effectiveness, it appears to have spiked interest in investing in Alzheimer’s drug companies, something that had been on the decline for several years.

  June 8, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Indivior Licenses Medication for Cannabis Use Disorder and Cannabis-Induced Psychosis

  Indivior PLC is collaborating with France-based Aelis Farma on the development of a treatment for cannabis use disorder and cannabis-induced psychosis.

  June 8, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  Entrepreneur Explains How the Pandemic Has Affected Women in the Workplace

  BioSpace recently interviewed Elizabeth Elting, founder and CEO of the Elizabeth Elting Foundation, to discuss her thoughts on how the pandemic has affected women in the workforce.

  June 8, 2021

   · 

  8 min read

   · 

  Porschia Parker-Griffin
• 

  Drug Development

  ASCO: On Target-Made Fluorescent Marker Boosts Ovarian Cancer Surgery Chances

  The tool developed by On Target boosts the ability of surgeons to find and remove cancerous lesions during surgical procedures, increasing progression free and overall survival.

  June 8, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  BioForest

  COVID-19 News: Inovio’s DNA Vaccine Candidate, Hearing Loss with Delta Variant and More

  Please check out the biopharma industry’s COVID-19 stories that are trending for June 8, 2021.

  June 8, 2021

   · 

  5 min read

   · 

  BioSpace Editorial Staff
• 

  Drug Development

  Starton Therapeutics Pitches Transdemeral Dosing Technology on “Unicorn Hunters”

  Unicorn Hunters is a new Internet reality show where startup companies can pitch a group of well-known panelists dubbed the “Circle of Money” which allows for a kind of crowdsourced funding appeal.

  June 8, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Exavir’s Long-Acting Antiretroviral Shows Promise for HIV in Animal Models

  The findings also highlight additional mechanistic, drug product stability, pharmacokinetics and toxicology studies that support the candidate as a potential HIV prevention and treatment.

  June 8, 2021

   · 

  3 min read

   · 

  Brandon May